Self Drainage in Pediatric Cystic Fibrosis Patients (GYM-MUCO)
This study has been completed.
Sponsor:
Hospices Civils de Lyon
Information provided by (Responsible Party):
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT01509235
First received: January 10, 2012
Last updated: May 7, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
In the current study, we designed a cross-over, open label, randomized controlled clinical trial that aim to investigate the superiority of physical exercise coupled with self drainage to a chest physiotherapy in stable cystic fibrosis children. We hypothesized that CF children undergoing physical exercise coupled to self drainage will increase the amount of expectorate secretions compared to conventional CP course, while being more satisfied and without worsening their pulmonary function status.
| Condition | Intervention |
|---|---|
|
Cystic Fibrosis |
Procedure: Chest physiotherapy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | Exercise Coupled to Self Drainage in Pediatric Cystic Fibrosis Patients: an Open Label Cross Over Randomised Clinical Trial |
Resource links provided by NLM:
Further study details as provided by Hospices Civils de Lyon:
Primary Outcome Measures:
- weight of sputum that was expectorated [ Time Frame: 12 months ] [ Designated as safety issue: No ]The Physiotherapist collected all sputum excreted from the beginning of the session and during the first hour.
Secondary Outcome Measures:
- patient's satisfaction [ Time Frame: 12 months ] [ Designated as safety issue: No ]evaluation of FEV1 before and after the session, ii) sessions' quality (i.e. patients' cooperation), iii) patient's satisfaction. Patient's cooperation was quoted by the physiotherapist from 1 (patient refused to participate) to 5 (excellent participation). Patients' satisfaction was scored using a visual analogic scale (VAS) graduated from 0 (not satisfied at all) to 100 (totally satisfied)
| Enrollment: | 34 |
| Study Start Date: | March 2006 |
| Study Completion Date: | March 2008 |
| Primary Completion Date: | March 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1. Exercise testing and self drainage session |
Procedure: Chest physiotherapy
The whole exercise session consisted of three short period of exercise of 5 minutes each entirely done under the physiotherapists' supervision (FA).
|
| Active Comparator: 2. Chest physiotherapy (CP) session |
Procedure: Chest physiotherapy
The whole exercise session consisted of three short period of exercise of 5 minutes each entirely done under the physiotherapists' supervision (FA).
|
Eligibility| Ages Eligible for Study: | 7 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Cystic fibrosis diagnosis confirmed by 2 positive sudoriparous diagnostic tests
- Age : 7 to 17 years
- Capacity to expectorate
- Clinically stable
- Ability to pedal on a bike and to respect orders for physical session
Exclusion Criteria:
- Haemoptysis > 50ml
- Permanent non-invasive ventilation
- Respiration or digestive evolutive clinical abnormality
- Exacerbation
Contacts and Locations
More Information
No publications provided by Hospices Civils de Lyon
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Hospices Civils de Lyon |
| ClinicalTrials.gov Identifier: | NCT01509235 History of Changes |
| Other Study ID Numbers: | 2005.403 |
| Study First Received: | January 10, 2012 |
| Last Updated: | May 7, 2012 |
| Health Authority: | France: Direction Générale de la Santé |
Keywords provided by Hospices Civils de Lyon:
|
cystic fibrosis Lung function physical exercise |
Additional relevant MeSH terms:
|
Cystic Fibrosis Fibrosis Pancreatic Diseases Digestive System Diseases Lung Diseases |
Respiratory Tract Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on June 18, 2013